Instead, mTOR activation by suppressing its physiological inhibitor tuberose sclerosis complex (TSC)2 causes hypoxia-induced glioma cell death by earlier ATP depletion and reactive oxygen species (ROS) production. Here, MTOR is linked to central nervous system cancer.